Position in XNCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,789,725
+$5,831,004 QoQ
Shares Held
483,834
+197.9% QoQ
Ownership
0.651%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 208 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. XNCR ranks #67 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in XNCR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,789,725 | 483,834 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $1,958,721 | 162,415 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,718,867 | 112,271 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,018,373 | 86,818 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $756,925 | 96,301 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $437,589 | 41,127 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $424,682 | 21,118 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $753,243 | 39,791 | Shares | Defined | 2024-08-14 | |
| 2023-06-30 | $292,423 | 11,711 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $587,781 | 21,075 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $671,936 | 25,804 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $263,229 | 10,132 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $437,755 | 15,994 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $284,462 | 10,662 | Shares | Defined | 2022-05-16 | |
| 2021-09-30 | $304,456 | 9,322 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $330,759 | 9,590 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $325,275 | 7,554 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $397,163 | 9,103 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,284,065 | 33,103 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,080,400 | 33,356 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $622,639 | 20,838 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||